The Lovelace Biomedical Podcast: Recent Episodes
Lovelace Biomedical
Discussing everything drug development. From our lab in Albuquerque, New Mexico, we are a contract research organization spanning a historical 70 years, specializing in multidisciplinary preclinical research. Covering industry trends, new therapies and development, along with the ins and outs of preclinical studies, with some scientific guests along the way.
Jake sits down with our Director of Life Sciences, Melanie Doyle-Eisele, PhD to talk about what's inside Medical Countermeasure drug development. Oh, and Girl Scout cookies.
Jake talks about the public health perspective with regards to covid19 and the pandemic, with Dr. Robert Amler, from the School of Public Health at New York Medical College
On this week's episode, Jake talks to Dharmesh Desai, our Director of Immunology & Large Molecule Bioanalysis. Biomarkers and assays within drug development. How it works, and why it's important.
Jake McDonald PhD, Rachel Cooper DVM, MS, DACLAM , and Jane Lindborg discuss assessments in CNS targeting and dosing for gene therapy applications.
Listen to and download materials from a fantastic past webinar on this topic: https://www.multivu.com/players/English/8984851-lovelace-biomedical-webinar-neuroscience-gene-therapy-nonclinical-development/
Jake McDonald, PhD, VP Applied Sciences, Philip Kuehl, PhD, and Meghan Vermillion, DVM, PhD, DACLAM, Director of Comparative Medicine
Our first episode! We talk about infectious diseases, and inhaled delivery to target and treat diseases.